230 results on '"Kretschmer, A"'
Search Results
2. MP58-09 BASELINE HEALTH-RELATED QUALITY OF LIFE PREDICTS METASTASIS-FREE SURVIVAL IN MEN WITH INTERMEDIATE RISK PROSTATE CANCER FOLLOWING RADICAL PROSTATECTOMY
3. MP08-02 DEVELOPMENT OF DE NOVO FINANCIAL TOXICITY IN BLADDER CANCER PATIENTS FOLLOWING RADICAL CYSTECTOMY AND ITS IMPACT ON HEALTH-RELATED QUALITY OF LIFE
4. MP19-19 THE IMPACT OF MULTIPLE LESIONS IN PROSTATE MRI-INSIGHTS FROM THE YAU PROSTATE CANCER GROUP
5. MP68-17 DEVELOPMENT OF DE NOVO FINANCIAL TOXICITY IN PROSTATE CANCER PATIENTS AFTER RADICAL PROSTATECTOMY AND ITS IMPACT ON HEALTH-RELATED QUALITY OF LIFE
6. Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging–targeted Biopsy: A Study That Challenges the Dogma
7. Reply by Authors
8. PD44-03 EVALUATION OF GENDER SPECIFIC DIFFERENCES IN HEALTH-RELATED QUALITY OF LIFE FOR BLADDER CANCER PATIENTS AFTER RADICAL CYSTECTOMY - RESULTS FROM A LARGE PROSPECTIVE PROPENSITY SCORE-MATCHED COHORT
9. MP67-18 IMPACT OF PERSISTENT PSA IN SALVAGE RADICAL PROSTATECTOMY PATIENTS - A MULTICENTER STUDY
10. Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging–targeted Biopsy: A Study That Challenges the Dogma
11. PD44-03 EVALUATION OF GENDER SPECIFIC DIFFERENCES IN HEALTH-RELATED QUALITY OF LIFE FOR BLADDER CANCER PATIENTS AFTER RADICAL CYSTECTOMY - RESULTS FROM A LARGE PROSPECTIVE PROPENSITY SCORE-MATCHED COHORT
12. MP67-18 IMPACT OF PERSISTENT PSA IN SALVAGE RADICAL PROSTATECTOMY PATIENTS - A MULTICENTER STUDY
13. The Added Value of Baseline Health-Related Quality of Life in Predicting Survival in High-Risk Prostate Cancer Patients Following Radical Prostatectomy
14. The Detection of Prostate Cancer with Magnetic Resonance Imaging-Targeted Prostate Biopsies is Superior with the Transperineal vs the Transrectal Approach. A European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-Institutional Study
15. MP48-01 HOW TO OPTIMIZE PATIENT SELECTION BEFORE SALVAGE LYMPH NODE DISSECTION FOR NODAL RECURRENT PROSTATE CANCER: A NOVEL RISK STRATIFICATION TOOL
16. MP03-05 HOW DOES THE TYPE OF URINARY DIVERSION AFFECT HEALTH RELATED QUALITY OF LIFE (HRQOL) IN THE COURSE OF FOUR YEARS AFTER RADICAL CYSTECTOMY? - A PROPENSITY SCORE-MATCHED ANALYSIS
17. PD60-01 THE IMPACT OF BASELINE HEALTH-RELATED QUALITY OF LIFE ON BIOCHEMICAL RECURRENCE FREE SURVIVAL IN HIGH-RISK PROSTATE CANCER PATIENTS FOLLOWING RADICAL PROSTATECTOMY
18. PD11-08 A COMBINED BIOMARKER/MPMRI APPROACH PROVIDES ENHANCED CLINICAL INFORMATION PRIOR TO PROSTATE BIOPSY
19. MP22-10 HOW IS HEALTH-RELATED QUALITY OF LIFE AFFECTED BY SALVAGE CYSTECTOMY AND URINARY DIVERSION AS A LAST-LINE OPTION FOR BENIGN DISEASE
20. PD54-04 CHALLENGING THE DOGMA: SHOULD UNILATERAL PELVIC LYMPH NODE DISSECTION BE ENVISIONED IN THE MULTIPARAMETRIC PROSTATE MRI ERA?
21. PD10-08 THE IMPACT OF BASELINE HEALTH-RELATED QUALITY OF LIFE ON BLADDER-CANCER-SPECIFIC SURVIVAL IN PATIENTS TREATED WITH RADICAL CYSTECTOMY
22. PD10-08 THE IMPACT OF BASELINE HEALTH-RELATED QUALITY OF LIFE ON BLADDER-CANCER-SPECIFIC SURVIVAL IN PATIENTS TREATED WITH RADICAL CYSTECTOMY
23. MP03-05 HOW DOES THE TYPE OF URINARY DIVERSION AFFECT HEALTH RELATED QUALITY OF LIFE (HRQOL) IN THE COURSE OF FOUR YEARS AFTER RADICAL CYSTECTOMY? - A PROPENSITY SCORE-MATCHED ANALYSIS
24. PD60-01 THE IMPACT OF BASELINE HEALTH-RELATED QUALITY OF LIFE ON BIOCHEMICAL RECURRENCE FREE SURVIVAL IN HIGH-RISK PROSTATE CANCER PATIENTS FOLLOWING RADICAL PROSTATECTOMY
25. PD11-08 A COMBINED BIOMARKER/MPMRI APPROACH PROVIDES ENHANCED CLINICAL INFORMATION PRIOR TO PROSTATE BIOPSY
26. MP22-10 HOW IS HEALTH-RELATED QUALITY OF LIFE AFFECTED BY SALVAGE CYSTECTOMY AND URINARY DIVERSION AS A LAST-LINE OPTION FOR BENIGN DISEASE
27. PD54-04 CHALLENGING THE DOGMA: SHOULD UNILATERAL PELVIC LYMPH NODE DISSECTION BE ENVISIONED IN THE MULTIPARAMETRIC PROSTATE MRI ERA?
28. MP48-01 HOW TO OPTIMIZE PATIENT SELECTION BEFORE SALVAGE LYMPH NODE DISSECTION FOR NODAL RECURRENT PROSTATE CANCER: A NOVEL RISK STRATIFICATION TOOL
29. Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of 68 Ga-PSMA and 11 C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections
30. The Added Value of Baseline Health-Related Quality of Life in Predicting Survival in High-Risk Prostate Cancer Patients Following Radical Prostatectomy
31. Timing of Radiotherapy after Radical Prostatectomy: Effects on Health-Related Quality of Life
32. PD34-05 IMPACT OF PREVIOUS WHOLE PELVIS RADIATION THERAPY IN PATIENTS TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR PROSTATE CANCER NODE-ONLY RECURRENCE: EVALUATION OF SURGICAL, PATHOLOGICAL, AND ONCOLOGICAL OUTCOMES
33. V09-06 A NOVEL TECHNIQUE OF CONISATION OF THE URETERO-PELVIC RECONSTRUCTION DURING LAPAROSCOPIC AND ROBOTIC ASSISTED PYELOPLASTY IN CASES OF URETEROPELVIC JUNCTION OBSTRUCTION
34. MP40-03 PATIENT SELECTION FOR THE TREATMENT OF MODERATE TO SEVERE MALE URINARY STRESS INCONTINENCE IN HIGH-VOLUME SURGICAL CENTERS OF EXCELLENCE
35. MP79-01 EXTERNAL VALIDATION OF THE 2019 BRIGANTI NOMOGRAM FOR THE IDENTIFICATION OF PROSTATE CANCER PATIENTS WHO SHOULD BE CONSIDERED FOR AN EXTENDED PELVIC LYMPH NODE DISSECTION
36. MP79-02 PERFORMANCE CHARACTERISTICS OF PET/CT SCAN IN MEN TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR RECURRENT PROSTATE CANCER: A PER PATIENT ANALYSIS WITH PATHOLOGICAL CONFIRMATION ACCORDING TO EACH AREA OF DISSECTION
37. MP74-14 HEALTH-RELATED QUALITY OF LIFE AFTER OPEN AND ROBOT-ASSISTED RADICAL PROSTATECTOMY: A PROPENSITY SCORE MATCHED ANALYSIS
38. Reply by Authors
39. Editorial Comment
40. Reply by Authors
41. Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of 68 Ga-PSMA and 11 C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections
42. MP40-03 PATIENT SELECTION FOR THE TREATMENT OF MODERATE TO SEVERE MALE URINARY STRESS INCONTINENCE IN HIGH-VOLUME SURGICAL CENTERS OF EXCELLENCE
43. MP74-14 HEALTH-RELATED QUALITY OF LIFE AFTER OPEN AND ROBOT-ASSISTED RADICAL PROSTATECTOMY: A PROPENSITY SCORE MATCHED ANALYSIS
44. MP79-01 EXTERNAL VALIDATION OF THE 2019 BRIGANTI NOMOGRAM FOR THE IDENTIFICATION OF PROSTATE CANCER PATIENTS WHO SHOULD BE CONSIDERED FOR AN EXTENDED PELVIC LYMPH NODE DISSECTION
45. MP79-02 PERFORMANCE CHARACTERISTICS OF PET/CT SCAN IN MEN TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR RECURRENT PROSTATE CANCER: A PER PATIENT ANALYSIS WITH PATHOLOGICAL CONFIRMATION ACCORDING TO EACH AREA OF DISSECTION
46. Prognostic Features for Objectively Defined Urinary Continence after Radical Cystectomy and Ileal Orthotopic Neobladder in a Contemporary Cohort
47. PD17-08 COMPARING THE DIAGNOSTIC ACCURACY OF 68GA-PSMA AND 11C-CHOLINE PET/CTSCAN ACCORDING TO PSA LEVEL: A LARGE MULTI-INSTITUTIONAL ANALYSIS WITH HISTOLOGICAL VERIFICATION IN PATIENTS TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR RECURRENT PROSTATE CANCER
48. MP22-03 LONG-TERM ONCOLOGIC OUTCOMES OF PATIENTS TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR NODAL RECURRENCE OF PROSTATE CANCER: RESULTS FROM A LARGE, MULTI-INSTITUTIONAL SERIES
49. MP05-04 PREOPERATIVE THROMBOCYTOSIS IN PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR UROTHELIAL CANCER OF THE BLADDER- AN INDEPENDENT PROGNOSTIC PARAMETER FOR AN IMPAIRED ONCOLOGICAL OUTCOME
50. Editorial Comment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.